AVLSA
Atlas Venture Life Science Advisors Portfolio holdings
AUM
$662M
1-Year Est. Return
6.63%
1 Year Est. Return
+6.63%
AUM
$522M
AUM Growth
-$298M
(-36%)
Holding
14
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Kymera Therapeutics
KYMR
$4.28B
| $134M | 25.69% |
4,896,462
|
|
||
2
Disc Medicine
IRON
$3.13B
| $118M | 22.69% |
2,384,456
-125,000
|
|
||
3
Dyne Therapeutics
DYN
$2.33B
| $95.5M | 18.3% |
9,130,465
+1,111,111
|
|
||
4
Day One Biopharmaceuticals
DAWN
$738M
| $51M | 9.77% |
6,430,257
|
|
||
|
SION
5
Sionna Therapeutics
SION
$1.41B
| $38.6M | 7.41% |
+3,694,020
|
|
||
|
THRD
6
DELISTED
Third Harmonic Bio
THRD
| $36.1M | 6.92% |
10,402,286
|
|
||
7
Korro Bio
KRRO
$396M
| $19.8M | 3.79% |
1,137,149
|
|
||
|
VIGL
8
DELISTED
Vigil Neuroscience
VIGL
| $10.4M | 1.99% |
5,836,874
|
|
||
|
IMA
9
ImageneBio Inc
IMA
$84.3M
| $6.42M | 1.23% |
418,182
|
|
||
|
JBIO
10
Jade Biosciences
JBIO
$431M
| $4.52M | 0.87% |
51,407
|
|
||
11
Q32 Bio
QTTB
$38.7M
| $3.45M | 0.66% |
2,092,106
|
|
||
12
Generation Bio
GBIO
$41.6M
| $3.35M | 0.64% |
827,948
|
|
||
13
Spero Therapeutics
SPRO
$124M
| $220K | 0.04% |
305,255
|
|
||
|
TECX
14
Tectonic Therapeutic
TECX
$323M
| – | – |
-78,447
|
|